About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

PHARMO Institute Seroquel Safety Study

NCT01342120·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

With

PHARMO Institute for Drug Outcomes Research

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Episode of new use of atypical antipsychotics in naïve (not used antipsychotic drugs for a year) users of antipsychotics.

You may not be if

less than a year of recorded history before the cohort entry date
use of multiple antipsychotics concomitantly
duration and dose of the antipsychotic drug cannot be determined

The record

StatusCompleted

PhaseNo phase

Taking part18,325

StartedSep 2010

UpdatedSep 2, 2011

Conditions

Schizophrenia Major Depressive Disorder Bipolar Disorder Generalized Anxiety Disorder

Clareo Health | PHARMO Institute Seroquel Safety Study